Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2021-11, Vol.62 (13), p.3300-3303
Main Authors: Wan, Chao-Ling, Zou, Jing-Ying, Qiao, Man, Yin, Jia, Shen, Xiang-Dong, Qiu, Qiao-Cheng, Liu, Song-Bai, Xue, Sheng-Li
Format: Article
Language:English
Subjects:
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Azacitidine - adverse effects
Bridged Bicyclo Compounds, Heterocyclic - adverse effects
Humans
Leukemia, Myeloid, Acute - drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Salvage Therapy
Sulfonamides
T-Lymphocytes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2021.1957876